These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23172728)

  • 1. Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences.
    Hussein SM; Elbaz J; Nagy AA
    Bioessays; 2013 Mar; 35(3):152-62. PubMed ID: 23172728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.
    Lu J; Li H; Baccei A; Sasaki T; Gilbert DM; Lerou PH
    Stem Cells Dev; 2016 May; 25(9):740-7. PubMed ID: 26935587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.
    Shimada M; Tsukada K; Kagawa N; Matsumoto Y
    J Radiat Res; 2019 Nov; 60(6):719-728. PubMed ID: 31665364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Regulation Along the Course of Cellular Reprogramming to Pluripotency.
    Ishtiaq M; Waseem M; Mehmood R
    Curr Mol Med; 2018; 18(1):58-64. PubMed ID: 29663886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: induced pluripotency by defined factors: prey of oxidative stress.
    Qi S; Fang Z; Wang D; Menendez P; Yao K; Ji J
    Stem Cells; 2015 May; 33(5):1371-6. PubMed ID: 25594616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic stability during cellular reprogramming: Mission impossible?
    von Joest M; Búa Aguín S; Li H
    Mutat Res; 2016 Jun; 788():12-6. PubMed ID: 26851988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
    Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
    Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
    Ying SY; Fang W; Lin SL
    Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Isolation of Poised iPSC Intermediates Reveals Principles of Cellular Reprogramming.
    Schwarz BA; Cetinbas M; Clement K; Walsh RM; Cheloufi S; Gu H; Langkabel J; Kamiya A; Schorle H; Meissner A; Sadreyev RI; Hochedlinger K
    Cell Stem Cell; 2018 Aug; 23(2):289-305.e5. PubMed ID: 30017590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to generate induced pluripotent stem cells.
    Hayes M; Zavazava N
    Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells.
    Gómez-Cabello D; Checa-Rodríguez C; Abad M; Serrano M; Huertas P
    Stem Cell Reports; 2017 Feb; 8(2):432-445. PubMed ID: 28065643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.